{"product_id":"advances-in-noninvasive-carotid-wall-imaging-with-ultrasound-what-patients-need-to-know","title":"Advances in Noninvasive Carotid Wall Imaging with Ultrasound: What Patients Need to Know","description":"\u003cp\u003eCarotid atherosclerosis—a buildup of plaque in the neck arteries—is a leading cause of stroke, and this review explains how modern ultrasound technology has moved far beyond simply measuring how narrow the artery has become. Researchers now recognize that the \u003cem\u003echaracteristics\u003c\/em\u003e of the plaque itself—whether it is soft and fatty, whether it has a thin or ruptured cap, whether it contains new blood vessels or microcalcifications—are critical predictors of stroke risk. This article translates the latest advances in noninvasive carotid wall imaging, including plaque echogenicity grading, Gray-Scale Median (GSM) analysis, contrast-enhanced ultrasound (CEUS), and elastography, into clear, actionable information for patients and their families.\u003c\/p\u003e\n\n\u003ch1\u003eAdvances in Noninvasive Carotid Wall Imaging with Ultrasound: What Patients Need to Know\u003c\/h1\u003e\n\n\u003ch2\u003eTable of Contents\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"#ddn-key-points\"\u003eKey Points\u003c\/a\u003e\u003c\/li\u003e\n\n  \u003cli\u003e\u003ca href=\"#background\"\u003eBackground: Why Carotid Artery Health Matters\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#shift\"\u003eThe Shift from \"How Narrow\" to \"How Vulnerable\"\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#echogenicity\"\u003ePlaque Echogenicity: What the \"Brightness\" of Plaque Tells Us\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#gsm\"\u003eGray-Scale Median (GSM): Putting a Number on Plaque Risk\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#jba\"\u003eJuxtaluminal Black Area (JBA): A New Marker of Danger\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#fibrous\"\u003eThe Fibrous Cap: The Plaque's \"Safety Shield\"\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#microcalcifications\"\u003eMicrocalcifications and the \"Firefly Sign\"\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#ceus\"\u003eContrast-Enhanced Ultrasound (CEUS): Seeing the Plaque's Blood Supply\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#elastography\"\u003eElastography: Measuring Plaque Stiffness\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#clinical\"\u003eClinical Implications: What This Means for Patients\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#limitations\"\u003eLimitations of Current Ultrasound Techniques\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#recommendations\"\u003eRecommendations for Patients\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#ddn-faq\"\u003eFrequently Asked Questions\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#source\"\u003eSource Information\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003c!-- ddn:keypoints:start --\u003e\n\u003ch2 id=\"ddn-key-points\"\u003eKey Points\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003eCarotid plaque vulnerability, not just stenosis, determines stroke risk; modern ultrasound assesses plaque composition.\u003c\/li\u003e\n\u003cli\u003eDark (hypoechoic) plaques and low Gray-Scale Median values indicate higher stroke risk.\u003c\/li\u003e\n\u003cli\u003eJuxtaluminal Black Area (JBA) size predicts annual stroke risk: 4-8 mm: 1.4%, 8-10 mm: 3.2%, \u0026gt;10 mm: 5%.\u003c\/li\u003e\n\u003cli\u003eContrast-enhanced ultrasound (CEUS) detects intraplaque neovascularization, a marker of plaque instability.\u003c\/li\u003e\n\u003cli\u003eElastography measures plaque stiffness, helping identify soft, vulnerable plaques; high-dose statins may increase plaque echogenicity and stability.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c!-- ddn:keypoints:end --\u003e\n\n\n\u003ch2 id=\"background\"\u003eBackground: Why Carotid Artery Health Matters\u003c\/h2\u003e\n\n\u003cp\u003eYour carotid arteries are the two large blood vessels on either side of your neck that carry oxygen-rich blood from your heart to your brain. When these arteries become narrowed or blocked by a buildup of fatty deposits, cholesterol, and other substances—a condition called carotid atherosclerosis—the consequences can be devastating.\u003c\/p\u003e\n\n\u003cp\u003eCarotid atherosclerosis is a major cause of transient ischemic attacks (TIAs, often called \"mini-strokes\") and full-blown strokes, which are associated with significant illness and death in Western societies. According to this review, ultrasound remains the first-line imaging modality for screening, diagnosing, grading, and following up on carotid atherosclerotic disease. The technique's value lies not only in its cost-effectiveness, widespread availability, excellent safety profile, and reproducibility, but also in its evolving multiparametric nature.\u003c\/p\u003e\n\n\u003cp\u003eMultiparametric ultrasound combines anatomic information from B-mode imaging (which creates a two-dimensional grayscale picture of the artery) with flow-visualization techniques and physiologic information acquired through pulsed-wave Doppler techniques (which measure the speed and direction of blood flow). Two newer additions—contrast-enhanced ultrasound (CEUS) and elastography—have expanded the diagnostic information available for evaluating carotid atherosclerosis.\u003c\/p\u003e\n\n\u003ch2 id=\"shift\"\u003eThe Shift from \"How Narrow\" to \"How Vulnerable\"\u003c\/h2\u003e\n\n\u003cp\u003eFor decades, doctors relied almost exclusively on one measurement to predict stroke risk: the percentage of luminal stenosis, or how much the plaque was blocking the artery. However, this traditional approach has been increasingly criticized. Both studies and clinical observations have shown that certain plaques producing milder degrees of stenosis may still lead to acute cerebral infarction (stroke).\u003c\/p\u003e\n\n\u003cp\u003eThe concept of the \"vulnerable plaque\" has emerged as a paradigm shift in how we think about stroke risk. A vulnerable plaque is one that is prone to rupture, leading to blood clot formation, acute occlusion of the artery, and embolic events (where a clot breaks off and travels to the brain). The main vulnerability features of carotid plaques include:\u003c\/p\u003e\n\n\u003cul\u003e\n  \u003cli\u003eLipid-rich necrotic core (a soft, fatty center)\u003c\/li\u003e\n  \u003cli\u003eIntraplaque hemorrhage (bleeding inside the plaque)\u003c\/li\u003e\n  \u003cli\u003eSuperficial ulcerations (breaks in the plaque surface)\u003c\/li\u003e\n  \u003cli\u003eThin or ruptured fibrous cap (the protective covering)\u003c\/li\u003e\n  \u003cli\u003eIntraplaque neovascularization (new, fragile blood vessels growing into the plaque)\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eThis shift in thinking is particularly important for a condition called embolic stroke of undetermined source (ESUS). The concept that ESUS is primarily of cardiogenic origin (originating from the heart) and potentially merits anticoagulation has not been confirmed by randomized clinical trials. Instead, nonstenosing thrombogenic atheromas (plaques that don't significantly narrow the artery but are prone to clot formation) may be the underlying pathology in a significant proportion of the etiologically heterogeneous ESUS population.\u003c\/p\u003e\n\n\u003cp\u003eThe numbers are striking: large non-stenosing internal carotid artery plaques on the same side as the cerebral ischemia (ipsilateral) have been identified in \u003cstrong\u003e35% of ESUS patients\u003c\/strong\u003e using CT angiography and in \u003cstrong\u003e25%\u003c\/strong\u003e using color Doppler imaging. Furthermore, intraplaque hemorrhage was identified using MRI in ipsilateral carotid atheromas in \u003cstrong\u003eone out of five patients with ESUS\u003c\/strong\u003e.\u003c\/p\u003e\n\n\u003cp\u003eThis means that a considerable percentage of stroke survivors with symptomatic carotid plaques have \u003cstrong\u003eless than 70% stenosis\u003c\/strong\u003e—a level that would traditionally have been considered relatively low risk. The traditional parameters used for describing carotid atheromas (degree of stenosis and systolic peak velocity) now appear to be insufficient predictors of the risk of embolization.\u003c\/p\u003e\n\n\u003ch2 id=\"echogenicity\"\u003ePlaque Echogenicity: What the \"Brightness\" of Plaque Tells Us\u003c\/h2\u003e\n\n\u003cp\u003ePlaque formation is the result of a chronic, progressive inflammatory process leading to deposits inside the sub-endothelial layer of the carotid wall. These deposits consist of lipids (fats), connective tissue extracellular matrix (collagen, proteoglycans, fibronectin, and elastic fibers), and cells such as macrophages, T-lymphocytes, and smooth muscle cells. Plaque echogenicity—how bright or dark a plaque appears on ultrasound—is the imaging visualization of this process.\u003c\/p\u003e\n\n\u003cp\u003eIn a historical study from the late 1980s, Gray-Weale and colleagues studied the importance of carotid plaque echogenicity, showing a correlation between the preoperative ultrasound appearance of atherosclerotic carotid plaques and the histological characteristics of carotid endarterectomy specimens (tissue removed during surgery). They demonstrated that plaques of lower echogenicity (darker appearance) were associated with an increased frequency of hemorrhage and lipid burden.\u003c\/p\u003e\n\n\u003cp\u003eBased on B-mode ultrasound, Gray-Weale and Nicolaides proposed a grading system based on echogenicity that classifies atherosclerotic plaques into five types:\u003c\/p\u003e\n\n\u003col\u003e\n  \u003cli\u003e\n\u003cstrong\u003eType 1:\u003c\/strong\u003e Uniformly echolucent (completely dark, soft appearance)\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eType 2:\u003c\/strong\u003e Predominantly echolucent with small areas of echogenicity (mostly dark with some bright spots)\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eType 3:\u003c\/strong\u003e Predominantly echogenic with small areas of echolucency (mostly bright with some dark spots)\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eType 4:\u003c\/strong\u003e Uniformly echogenic (completely bright, hard appearance)\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eType 5:\u003c\/strong\u003e Plaques that could not be classified due to heavy calcification and acoustic shadows (where calcium blocks the ultrasound beam)\u003c\/li\u003e\n\u003c\/ol\u003e\n\n\u003cp\u003eHypoechoic plaques (types 1 and 2) are associated with intraplaque hemorrhage and lipid accumulation, whereas hyperechoic homogeneous plaques (types 3 and 4) are predominantly fibrous or calcified in nature. As a result, the first two categories appear to be associated with a higher risk for surface disruption or rupture and yield a subsequent significantly higher risk of ipsilateral stroke when compared with non-echolucent plaques.\u003c\/p\u003e\n\n\u003cp\u003eOn the contrary, types 4 and 5 plaques are mainly encountered in patients with asymptomatic carotid disease (those who have not yet experienced symptoms). Calcifications have been found to play an important role in plaque stabilization, and lipid-rich plaques appear to be more often actively inflamed than either calcified or collagen-rich (hyperechoic) plaques. Thus, heavily calcified carotid plaques could represent a chronic, less actively inflamed form of atherosclerosis.\u003c\/p\u003e\n\n\u003cp\u003eHowever, there is an important caveat: calcified intraluminal plaques may occasionally cause ischemia when the calcified material embolizes into the brain. The review illustrates a clinical case of a free-floating calcified plaque causing embolic stroke, where multiple calcific emboli were visible on brain CT scans.\u003c\/p\u003e\n\n\u003cp\u003eThe clinical significance of echolucent plaques extends beyond stroke risk. Patients with asymptomatic carotid plaques of low echogenicity have more frequently MRI (T2\/FLAIR) T2 hyperintensities in the periventricular and subcortical white matter, silent lacunar lesions, or cerebral microbleeds—all of which convey an increased risk of cognitive decline and vascular dementia. Moreover, echolucent plaques are associated with an increased risk of stroke in patients undergoing carotid stenting and are associated with new cerebral ischemic lesions following endarterectomy (surgical removal of the plaque).\u003c\/p\u003e\n\n\u003cp\u003eA study performed on \u003cstrong\u003e1,061 patients\u003c\/strong\u003e undergoing carotid endarterectomy associated plaque hypoechogenicity and ulcerations with the occurrence of new ischemic lesions on diffusion-weighted imaging \u003cstrong\u003e30 days post-surgery\u003c\/strong\u003e.\u003c\/p\u003e\n\n\u003cp\u003eA meta-analysis involving \u003cstrong\u003e7,557 asymptomatic patients\u003c\/strong\u003e followed for more than 3 years demonstrated that plaques described as echolucent, showing intraplaque neovascularization and ulceration, were associated with \u003cstrong\u003etwice the risk of ischemic symptoms\u003c\/strong\u003e compared to stable echogenic plaques.\u003c\/p\u003e\n\n\u003ch2 id=\"gsm\"\u003eGray-Scale Median (GSM): Putting a Number on Plaque Risk\u003c\/h2\u003e\n\n\u003cp\u003eWhile the Gray-Weale classification is useful, it is somewhat subjective. To address this, another parameter—the Gray-Scale Median (GSM)—was introduced to quantify plaque echogenicity in a more objective and reproducible manner.\u003c\/p\u003e\n\n\u003cp\u003eQuantitative assessment of the plaque is performed by a computer system that assigns certain gray-scale values to blood and adventitia (the outer layer of the artery wall). GSM values from known tissue components are used, and the measurement of the region of interest is expressed in a \u003cstrong\u003e256 gray-tone range where 0 is black and 255 is white\u003c\/strong\u003e. The GSM value of an entire plaque is obtained from a histogram calculated by software analysis.\u003c\/p\u003e\n\n\u003cp\u003ePlaques containing more calcium and fibrous tissue have higher GSM values, whereas plaques with richer lipid cores and hemorrhagic components have lower GSM values. Atherosclerotic lesions with lower GSM are more prone to rupture, and a lower GSM value may be considered an \u003cstrong\u003eindependent risk factor for stroke\u003c\/strong\u003e.\u003c\/p\u003e\n\n\u003cp\u003eCarotid bifurcation plaques in patients with silent non-lacunar infarcts (small areas of brain damage that occur without noticeable symptoms) are usually hypoechoic and of low GSM, even in the absence of critical luminal stenosis. This reinforces the message that plaque composition matters independently of the degree of narrowing.\u003c\/p\u003e\n\n\u003ch2 id=\"jba\"\u003eJuxtaluminal Black Area (JBA): A New Marker of Danger\u003c\/h2\u003e\n\n\u003cp\u003eDuring the last decade, the term \"juxtaluminal black area\" (JBA) has been introduced in the study of plaque echogenicity. JBA is defined as an area with a GSM value of \u003cstrong\u003eless than 25\u003c\/strong\u003e adjacent to the lumen (the open channel through which blood flows) without a visible fibrous cap. This area has been linked linearly to elevated stroke risk.\u003c\/p\u003e\n\n\u003cp\u003eHistologic studies performed on endarterectomy specimens have shown that JBA in ultrasound images is associated with lipid core proximity to the vascular lumen. The lipid-rich necrotic core is closer to the lumen in symptomatic plaques causing thromboembolic phenomena in comparison to more stable asymptomatic plaques.\u003c\/p\u003e\n\n\u003cp\u003eA study showed that the size of the JBA in asymptomatic carotid atheromas is linked to the possibility of a future ischemic event and can be used in stroke risk stratification models. The risk numbers are specific and important:\u003c\/p\u003e\n\n\u003cul\u003e\n  \u003cli\u003eA JBA of \u003cstrong\u003e4–8 mm\u003c\/strong\u003e: annual stroke risk of \u003cstrong\u003e1.4%\u003c\/strong\u003e\n\u003c\/li\u003e\n  \u003cli\u003eA JBA of \u003cstrong\u003e8–10 mm\u003c\/strong\u003e: annual stroke risk of \u003cstrong\u003e3.2%\u003c\/strong\u003e\n\u003c\/li\u003e\n  \u003cli\u003eA JBA of \u003cstrong\u003egreater than 10 mm\u003c\/strong\u003e: annual stroke risk of \u003cstrong\u003e5%\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eA JBA greater than 4 mm is considered a considerable carotid disease indicator. These numbers give doctors and patients a more precise way to estimate individual risk and make treatment decisions.\u003c\/p\u003e\n\n\u003ch2 id=\"fibrous\"\u003eThe Fibrous Cap: The Plaque's \"Safety Shield\"\u003c\/h2\u003e\n\n\u003cp\u003eThe fibrous cap is a layer of fibrous connective tissue containing macrophages and smooth-muscle cells within a collagen-proteoglycan matrix associated with T-lymphocytes. It covers the necrotic lipid core and constitutes a barrier separating the vascular lumen from the thrombogenic (clot-promoting) atheromatous contents of the plaque.\u003c\/p\u003e\n\n\u003cp\u003eThink of the fibrous cap as a safety shield: as long as it remains intact, the dangerous contents of the plaque are kept away from the bloodstream. Different caps vary in thickness, composition, and collagen content, and thus in stability. The rupture usually occurs in areas where the cap is the thinnest and often most heavily infiltrated by macrophage foam cells.\u003c\/p\u003e\n\n\u003cp\u003eFibrous cap thickness measurement of carotid atheromas with ultrasound is feasible, albeit technically demanding. Furthermore, discrimination of symptomatic from asymptomatic plaques based on ultrasound-measured mean cap thickness values is good and merits further development.\u003c\/p\u003e\n\n\u003cp\u003eHowever, there are limitations. Some fibrous caps may be so thin that they are usually not visible on classical ultrasound, while in heavily calcified plaques, cap visualization may be impossible. Newer high-resolution ultrasound devices with shear-wave elastography are able to visualize thick fibrous caps, especially in hypoechoic plaques.\u003c\/p\u003e\n\n\u003ch2 id=\"microcalcifications\"\u003eMicrocalcifications and the \"Firefly Sign\"\u003c\/h2\u003e\n\n\u003cp\u003eA recently introduced imaging technology called MicroPure™ (Toshiba Medical Systems Corp., Tokyo, Japan) may improve visualization of microcalcifications on ultrasound. These are tiny calcium deposits that are too small to be seen with conventional imaging but may be important markers of plaque vulnerability.\u003c\/p\u003e\n\n\u003cp\u003eThis imaging technology allows the identification of the \"Firefly sign\": microcalcifications are displayed as \u003cstrong\u003ewhite dots on a blue background\u003c\/strong\u003e, similar to fireflies flickering in the dark. These signs are located in the fibrous caps of carotid atheromas and may be associated with plaque vulnerability.\u003c\/p\u003e\n\n\u003cp\u003eA 4-point Firefly score system has been developed, and recent studies indicate that Firefly-positive atherosclerotic lesions are at an increased risk for rupture and embolic cerebral infarcts (strokes caused by clots traveling to the brain).\u003c\/p\u003e\n\n\u003ch2 id=\"ceus\"\u003eContrast-Enhanced Ultrasound (CEUS): Seeing the Plaque's Blood Supply\u003c\/h2\u003e\n\n\u003cp\u003eContrast-enhanced ultrasound (CEUS) represents one of the most significant recent advances in carotid wall imaging. This technique involves the injection of microbubbles (tiny gas-filled microspheres) into the bloodstream, which then circulate through the blood vessels and can be visualized on ultrasound.\u003c\/p\u003e\n\n\u003cp\u003eCEUS is particularly valuable for assessing intraplaque neovascularization—the growth of new, fragile blood vessels into the plaque itself. These new vessels are typically immature and leaky, allowing inflammatory cells and red blood cells to enter the plaque, which can contribute to plaque growth and instability. The presence and extent of intraplaque neovascularization as seen on CEUS has been correlated with:\u003c\/p\u003e\n\n\u003cul\u003e\n  \u003cli\u003eHistological evidence of neovascularization in endarterectomy specimens\u003c\/li\u003e\n  \u003cli\u003eIncreased plaque vulnerability\u003c\/li\u003e\n  \u003cli\u003eHigher risk of cerebrovascular events\u003c\/li\u003e\n  \u003cli\u003ePresence of symptoms (symptomatic plaques show more enhancement)\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eThe review emphasizes that CEUS can detect and grade the degree of intraplaque neovascularization, providing a functional assessment that complements the anatomic information from B-mode imaging. This is particularly valuable because intraplaque neovascularization is one of the key features of vulnerable plaques and cannot be reliably assessed with conventional ultrasound alone.\u003c\/p\u003e\n\n\u003ch2 id=\"elastography\"\u003eElastography: Measuring Plaque Stiffness\u003c\/h2\u003e\n\n\u003cp\u003eElastography is another recent addition to the ultrasound toolkit that measures the mechanical properties of tissue—specifically, its stiffness or elasticity. The principle is simple: different tissues have different stiffness, and this can be measured by how they respond to mechanical stress.\u003c\/p\u003e\n\n\u003cp\u003eIn carotid plaque assessment, shear-wave elastography (SWE) is the most commonly used technique. It works by using an acoustic radiation force impulse to generate shear waves in the tissue, and then measuring the speed of these waves. Faster shear-wave velocities indicate stiffer tissue.\u003c\/p\u003e\n\n\u003cp\u003eThe clinical value of elastography lies in its ability to differentiate between different plaque components:\u003c\/p\u003e\n\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eLipid-rich necrotic cores\u003c\/strong\u003e are typically soft (low stiffness, low shear-wave velocity)\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eFibrous tissue\u003c\/strong\u003e is moderately stiff\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCalcified tissue\u003c\/strong\u003e is very stiff (high shear-wave velocity)\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eThis information is complementary to echogenicity. A plaque that appears hypoechoic (dark) on B-mode could be either a soft lipid-rich plaque (high risk) or a relatively benign fibrous plaque. Elastography helps distinguish between these possibilities by measuring the actual mechanical properties of the tissue.\u003c\/p\u003e\n\n\u003cp\u003eThe review illustrates a clinical case where shear-wave elastography showed low shear-wave velocity values and thus lower stiffness in the plaque's core (appearing dark blue on the elastogram) but a slightly higher value and stiffness for the fibrous cap. This combination of findings—a soft core with a relatively stiffer cap—is characteristic of a vulnerable plaque.\u003c\/p\u003e\n\n\u003ch2 id=\"clinical\"\u003eClinical Implications: What This Means for Patients\u003c\/h2\u003e\n\n\u003cp\u003eThe advances described in this review have several important implications for patients at risk of stroke:\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eFirst, the degree of stenosis is no longer the sole determinant of risk.\u003c\/strong\u003e Patients with non-significant narrowing of their carotid arteries may still be at substantial risk if their plaques have vulnerable features. This is particularly relevant for the large population of patients with ESUS, where nonstenosing atheromas may be the underlying cause in a significant proportion of cases.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eSecond, modern ultrasound can provide a comprehensive \"plaque vulnerability profile.\"\u003c\/strong\u003e A state-of-the-art carotid ultrasound scan should now evaluate and report not just the degree of stenosis, but also plaque echogenicity (using both the Gray-Weale classification and GSM), surface morphology (looking for ulcerations), the presence of intraplaque neovascularization (using CEUS), plaque stiffness (using elastography), and the presence of microcalcifications (using MicroPure™ technology).\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eThird, treatment decisions can be better informed.\u003c\/strong\u003e The identification of vulnerable plaque features may influence decisions about:\u003c\/p\u003e\n\n\u003cul\u003e\n  \u003cli\u003eThe intensity of statin therapy (high-dose statins have been shown to increase plaque echogenicity, making plaques less prone to rupture)\u003c\/li\u003e\n  \u003cli\u003eThe choice between medical management and revascularization (carotid endarterectomy or stenting)\u003c\/li\u003e\n  \u003cli\u003eThe timing of intervention in asymptomatic patients\u003c\/li\u003e\n  \u003cli\u003eThe need for more aggressive risk factor modification\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003e\u003cstrong\u003eFourth, monitoring treatment response is possible.\u003c\/strong\u003e A plaque that appears to become progressively more echogenic over time is possibly an indicator that its histological composition is changing and its stability is increasing. Early and aggressive treatment with statins at high doses seems to increase the echogenicity of carotid plaques, making them less prone to rupture. This means that ultrasound can be used not just for diagnosis but also for monitoring the effectiveness of medical therapy.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eFifth, the field is moving toward artificial intelligence.\u003c\/strong\u003e There has been a lot of research during the last years toward the use of radiomics and machine learning. Carotid ultrasound, being operator-dependent, is expected to benefit from the use of artificial intelligence. Ultrasound-based radiomics models can be constructed by extracting features from grayscale images and may identify and quantify target features such as total plaque volume and composition (calcium, intraplaque hemorrhage, lipids), thereby predicting cerebrovascular ischemia risk. Latest studies show that radiomics can reveal information invisible on advanced ultrasound imaging.\u003c\/p\u003e\n\n\u003ch2 id=\"limitations\"\u003eLimitations of Current Ultrasound Techniques\u003c\/h2\u003e\n\n\u003cp\u003eWhile the advances described in this review are significant, it is important to acknowledge the limitations of current ultrasound techniques:\u003c\/p\u003e\n\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eOperator dependence:\u003c\/strong\u003e Ultrasound is highly operator-dependent. The quality of the examination and the accuracy of measurements depend significantly on the skill and experience of the sonographer. This is one of the main reasons why artificial intelligence and radiomics are expected to play an increasingly important role.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTechnical limitations with calcified plaques:\u003c\/strong\u003e Heavy calcification can create acoustic shadows that obscure the underlying tissue, making it impossible to assess certain plaque features. Type 5 plaques in the Gray-Weale classification cannot be classified due to this limitation.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDifficulty visualizing thin fibrous caps:\u003c\/strong\u003e Some fibrous caps may be so thin that they are not visible on classical ultrasound, while in heavily calcified plaques, cap visualization may be impossible.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eLimited penetration depth:\u003c\/strong\u003e Ultrasound has limited penetration depth, which can be a problem in patients with thick necks or deep carotid bifurcations.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCEUS requires intravenous access:\u003c\/strong\u003e Contrast-enhanced ultrasound requires an intravenous injection, which adds time, cost, and a small risk of adverse reactions (though the safety profile of ultrasound contrast agents is excellent).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eElastography is technically demanding:\u003c\/strong\u003e Shear-wave elastography requires specialized equipment and expertise, and measurements can be affected by patient movement, breathing, and the pulsation of the carotid artery itself.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNot all features can be assessed in a single examination:\u003c\/strong\u003e A comprehensive multiparametric assessment may require multiple acquisitions and specialized probes, which may not be available in all centers.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2 id=\"recommendations\"\u003eRecommendations for Patients\u003c\/h2\u003e\n\n\u003cp\u003eBased on the findings of this review, here are actionable recommendations for patients:\u003c\/p\u003e\n\n\u003col\u003e\n  \u003cli\u003e\n\u003cstrong\u003eKnow your plaque, not just your stenosis percentage.\u003c\/strong\u003e If you have been told you have carotid atherosclerosis, ask your doctor about the characteristics of your plaque—not just the degree of narrowing. Ask about echogenicity, surface features, and whether advanced imaging techniques like CEUS or elastography are available.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIf you have had a stroke or TIA of undetermined cause, ask about carotid plaque assessment.\u003c\/strong\u003e Given that nonstenosing atheromas may be the underlying cause in a significant proportion of ESUS patients, a detailed carotid ultrasound evaluation looking for vulnerable plaque features is warranted.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTake statin therapy seriously.\u003c\/strong\u003e High-dose statins have been shown to increase plaque echogenicity, making plaques less prone to rupture. Even if your cholesterol levels are not dramatically elevated, statin therapy may be beneficial for plaque stabilization.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eControl all cardiovascular risk factors.\u003c\/strong\u003e This includes blood pressure control, diabetes management, smoking cessation, and lifestyle modifications. These measures can slow the progression of atherosclerosis and may promote plaque stabilization.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAsk about follow-up imaging.\u003c\/strong\u003e If you have vulnerable plaque features, ask your doctor about appropriate follow-up intervals. Serial ultrasound examinations can monitor changes in plaque characteristics over time.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBe aware of silent brain changes.\u003c\/strong\u003e Echolucent plaques are associated with silent lacunar lesions, cerebral microbleeds, and white matter changes that convey an increased risk of cognitive decline and vascular dementia. If you have echolucent plaques, discuss cognitive health monitoring with your doctor.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSeek centers with advanced capabilities.\u003c\/strong\u003e If you are at high risk or have complex plaque features, consider seeking evaluation at a center that offers multiparametric carotid ultrasound, including CEUS and elastography.\u003c\/li\u003e\n\u003c\/ol\u003e\n\n\u003cp\u003eIn summary, the field of carotid wall imaging has evolved dramatically. The traditional focus on the degree of stenosis has been replaced by a more nuanced understanding of plaque vulnerability. Modern ultrasound, with its multiparametric capabilities, is well-suited to provide accurate evaluation of the vulnerability of carotid plaques. For patients, this means more precise risk stratification, better-informed treatment decisions, and the potential for earlier intervention to prevent devastating strokes.\u003c\/p\u003e\n\n\u003c!-- ddn:faq:start --\u003e\n\u003ch2 id=\"ddn-faq\"\u003eFrequently Asked Questions\u003c\/h2\u003e\n\u003ch3\u003eWhat is carotid atherosclerosis and why is it dangerous?\u003c\/h3\u003e\n\u003cp\u003eCarotid atherosclerosis is a buildup of fatty deposits, cholesterol, and other substances in the carotid arteries, the large blood vessels on each side of your neck that supply blood to your brain. This buildup can narrow or block the arteries, and it is a major cause of transient ischemic attacks (TIAs or mini-strokes) and full-blown strokes.\u003c\/p\u003e\n\u003ch3\u003eWhy is the degree of narrowing not the only factor in stroke risk?\u003c\/h3\u003e\n\u003cp\u003eTraditional risk assessment focused only on how much the plaque blocks the artery. However, research shows that some plaques causing milder narrowing can still lead to stroke. The concept of the 'vulnerable plaque' emphasizes that plaque characteristics—such as a soft, fatty core, a thin or ruptured cap, or new blood vessels—are critical predictors of stroke risk, even when stenosis is less than 70%.\u003c\/p\u003e\n\u003ch3\u003eWhat is plaque echogenicity and what does it mean for my stroke risk?\u003c\/h3\u003e\n\u003cp\u003ePlaque echogenicity refers to how bright or dark a plaque appears on ultrasound. Darker (hypoechoic) plaques are associated with hemorrhage and lipid accumulation, making them more prone to rupture and causing a higher risk of stroke. Brighter (hyperechoic) plaques are more fibrous or calcified and are generally more stable. This is graded using the Gray-Weale classification.\u003c\/p\u003e\n\u003ch3\u003eWhat is the Gray-Scale Median (GSM) and how is it used?\u003c\/h3\u003e\n\u003cp\u003eGray-Scale Median (GSM) is a computer-based method that assigns a numerical value (0 to 255) to the overall brightness of a plaque on ultrasound. Lower GSM values indicate softer, lipid-rich plaques that are more prone to rupture, while higher values indicate more calcified or fibrous plaques. A lower GSM is considered an independent risk factor for stroke.\u003c\/p\u003e\n\u003ch3\u003eWhat is the Juxtaluminal Black Area (JBA) and what does it mean for my risk?\u003c\/h3\u003e\n\u003cp\u003eJuxtaluminal Black Area (JBA) is a dark area (GSM less than 25) adjacent to the artery lumen, indicating a lipid core close to the surface. The size of JBA is linked to stroke risk: 4-8 mm gives an annual stroke risk of 1.4%, 8-10 mm gives 3.2%, and greater than 10 mm gives 5%. A JBA greater than 4 mm is considered significant.\u003c\/p\u003e\n\u003ch3\u003eWhat is contrast-enhanced ultrasound (CEUS) and why is it used?\u003c\/h3\u003e\n\u003cp\u003eContrast-enhanced ultrasound (CEUS) involves injecting tiny microbubbles into the bloodstream to visualize blood flow. It is particularly valuable for detecting intraplaque neovascularization—new, fragile blood vessels that grow into the plaque. These vessels are leaky and can contribute to plaque instability. CEUS can grade the degree of neovascularization, which is a key feature of vulnerable plaques.\u003c\/p\u003e\n\u003ch3\u003eWhat is elastography and how does it help assess carotid plaques?\u003c\/h3\u003e\n\u003cp\u003eElastography measures the stiffness of tissue using shear-wave ultrasound. In carotid plaques, it can differentiate between soft lipid-rich cores (low stiffness) and harder fibrous or calcified tissue (high stiffness). This complements echogenicity, helping to identify vulnerable plaques that have a soft core and a stiffer cap, which are more prone to rupture.\u003c\/p\u003e\n\u003c!-- ddn:faq:end --\u003e\n\n\u003ch2 id=\"source\"\u003eSource Information\u003c\/h2\u003e\n\n\u003cp\u003e\u003cstrong\u003eOriginal Article Title:\u003c\/strong\u003e Greece Noninvasive Carotid Wall Imaging with Ultrasound- A Narrative Review\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eAuthors:\u003c\/strong\u003e Maria Alexandratou, Angeliki Papachristodoulou, Xin Li, Sasan Partovi, Andjoli Davidhi, Vasileios Rafailidis, Panos Prassopoulos, Vasileios Kamperidis, Ioanna Koutroulou, Georgios Tsivgoulis, Nikolaos Grigoriadis, Christos Krogias, and Theodore Karapanayiotides\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eJournal:\u003c\/strong\u003e Journal of Clinical Medicine, 2022, Volume 11, Issue 20, Article 6196\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003ePublication Date:\u003c\/strong\u003e October 20, 2022\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eAffiliations:\u003c\/strong\u003e Department of Clinical Radiology, AHEPA University Hospital of Thessaloniki, Aristotle University of Thessaloniki, Greece; Department of Radiology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA; Section of Interventional Radiology, Imaging Institute, Cleveland Clinic Main Campus, Cleveland, OH, USA; 1st Cardiology Department, School of Medicine, AHEPA University Hospital, Aristotle University of Thessaloniki, Greece; 2nd Department of Neurology, School of Medicine, AHEPA University Hospital, Aristotle University of Thessaloniki, Greece; Second Department of Neurology, School of Medicine, 'Attikon' University Hospital, National and Kapodistrian University of Athens, Greece; Department of Neurology, St. Josef-Hospital Bochum, Ruhr University Bochum, Germany.\u003c\/p\u003e\n\n\u003cp\u003e\u003cem\u003eThis patient-friendly article is based on peer-reviewed research published in an open-access journal under the Creative Commons Attribution (CC BY) license. It has been written to make the findings accessible to a general audience while preserving all key data, statistics, and conclusions from the original scientific publication.\u003c\/em\u003e\u003c\/p\u003e","brand":"DiagnosticDetectives.Com","offers":[{"title":"Default Title","offer_id":47306621386908,"sku":null,"price":0.0,"currency_code":"EUR","in_stock":true}],"url":"https:\/\/diagnosticdetectives.it\/products\/advances-in-noninvasive-carotid-wall-imaging-with-ultrasound-what-patients-need-to-know","provider":"DiagnosticDetectives.Com","version":"1.0","type":"link"}